New Scientific Publication Released We are pleased to share our latest research publication exploring the…
Advancing Longevity Medicine: European Wellness at the GMH 2026 Exhibition

The 2026 Global Medical and Health Exhibition (GMH), held concurrently with the 4th Shenzhen Reproductive Medicine and Health Conference, convened from April 17 to 19 at the Shenzhen Convention & Exhibition Center. This premier event brought together leading professionals to explore the latest developments in regenerative medicine, functional medicine, and global health management. Among the prominent participants was European Wellness Biomedical Group, a Swiss-based organization specializing in cell therapy and anti-aging treatments.
Representing European Wellness and Prof. Dato’ Sri Dr. Mike Chan, Carmen Chuah delivered two compelling presentations on April 17, sharing insights into the future of longevity and the practical applications of regenerative therapies. Her talks provided attendees with a comprehensive understanding of how precision medicine is reshaping approaches to healthspan and disease management.

The Future of Longevity Medicine

During the morning session, Carmen Chuah presented on “The Future of Longevity Medicine Through Healthspan by Cellspan & Brainspan with Precision in Regenerative Medicine”. This presentation focused on the critical shift from merely extending lifespan to enhancing healthspan—the period of life spent in good health, free from chronic diseases and disabilities.
The concept of “Cellspan” and “Brainspan” was central to the discussion, emphasizing the importance of maintaining cellular vitality and cognitive function as we age. Chuah highlighted how precision in regenerative medicine allows for targeted interventions that address specific cellular deficiencies. By utilizing advanced therapies, practitioners can potentially slow the aging process at the cellular level, thereby promoting overall well-being and longevity.
The presentation underscored the necessity of personalized approaches in medicine. Rather than adopting a one-size-fits-all methodology, precision regenerative medicine tailors treatments to individual patient profiles, maximizing efficacy and minimizing adverse effects. This paradigm shift is essential for addressing the complex, multifactorial nature of aging and age-related diseases.
Evaluating Regenerative Therapies
In the afternoon session, Chuah tackled a more analytical topic: “Why Stem Cells, Peptides & Exosomes Work and Why They Don’t Work for Many Diseases & Untreatable Diseases”. This talk provided a critical evaluation of current regenerative modalities, offering a balanced perspective on their capabilities and limitations.
Chuah explained the mechanisms by which stem cells, peptides, and exosomes exert their therapeutic effects. Stem cells serve as the foundation for tissue repair and regeneration, while peptides act as targeted bioactive compounds that facilitate specific cellular functions. Exosomes, as cell-free therapeutic agents, play a crucial role in intercellular communication, delivering potent regenerative signals without the complexities associated with whole-cell treatments.
However, the presentation also addressed the reasons why these therapies may fail in certain contexts. Factors such as patient selection, disease stage, and the specific formulation of the treatment can significantly impact outcomes. For instance, while targeted brain-and-organ-specific precursor stem cell therapy may show promise for conditions like Down Syndrome—specifically targeting areas such as the Medulla Alba and frontal lobe—their efficacy depends heavily on precise application and patient-specific variables.
| Therapy Type | Mechanism of Action | Key Considerations for Efficacy |
|---|---|---|
| Precursor Stem Cells (PSC) | Tissue repair and cellular regeneration | Source quality, patient age, and disease stage |
| Peptides | Targeted bioactive signaling | Specificity of formulation and targeted delivery |
| Exosomes | Intercellular communication and signaling | Concentration, purity, and origin of exosomes |
Engaging with the Global Health Community
Beyond the presentations, European Wellness maintained a strong presence at Booth B55 throughout the exhibition. The booth served as a hub for engagement, where attendees could learn more about the organization’s comprehensive approach to youth restoration and medical wellness.
The exhibition space prominently featured information on Mito Organelle (Mitochondrial Peptides) and hair restoration products (HFR), demonstrating the practical applications of the theories discussed in the presentations. Visitors had the opportunity to engage in one-on-one consultations with European Wellness staff, including Carmen Chuah, fostering a deeper understanding of precision regenerative medicine.

The booth’s design highlighted the global reach of European Wellness, noting its presence in over 40 countries and its service to more than 60,000 patients worldwide. This international perspective aligns with the GMH exhibition’s goal of facilitating global medical resource docking and cross-border medical care.
Through both the insightful presentations by Carmen Chuah and the interactive booth experience, European Wellness demonstrated its commitment to advancing the field of longevity medicine. By addressing both the potential and the practical challenges of regenerative therapies, European Wellness continues to contribute valuable knowledge to the global health community.
Follow European Wellness Academy:























